About HTN Pro
HTN Pro Member Hub
HTN Live Events Archive
Weekly Health Tech Reads 11/22/2026
Nov 22, 2026
The consumer healthcare wars: Oura acquires Counsel; Ro re-emerges as a key player; Hims falters in Q3. Oh, also CMS's clinical AI roadmap
Nov 15, 2026
Five things from the week: CVS's big move, midterms, athena's agentic future, Devoted's commercial market entry, and Q3 earnings rundown
Nov 8, 2026
General Medicine and Zocdoc build out agentic AI infrastructure, Q3 earnings updates, the rapidly growing GLP-1 Bridge program, and more
Nov 1, 2026
Molina & Elevance Q3 earnings; a rule of 200 healthcare company; AI's principal-agent problem; the opportunity in drug discovery; lots of M&A; and more
Oct 25, 2026
UHG kicks off Q3 earnings season, Neko's waitlist and huge new space, Atrium and SHP continue fighting, and more
Oct 18, 2026
Atrium's spat with North Carolina's State Health Plan; AI consumers, healthcare stores, and Megan Fox; 2027 Stars; and more
Oct 11, 2026
Oura's postponed IPO, Devoted's $25 billion valuation, Cigna's specialty pharma play, the 2027 MA landscape emerges, Grindr's healthcare move, and more
Oct 4, 2026
The upcoming AI agent wars, Rightway's funding round, OpenEvidence's curious legal strategy, and more
Sep 27, 2026
A big week for alternative plan design funding, AI personal assistants are here, Oscar + Lucie, OpenEvidence's quiet funding round, and more
Sep 20, 2026
ARPA-H and the autonomous clinical AI debate; employer market disruption; Omada's investor day; PACE growth; and more
Sep 13, 2026
The Sword/Headspace merger, continued No Surprises Act arguments, Doximity data on provider compensation, and more
Aug 30, 2026
Devoted's "Beat and Raise", San Antonio's No Surprises Act conundrum, de-escalating the AI vs doctor debate, Hims' underwhelming vision, and more
Aug 23, 2026
A summary of Q2 earnings themes, Pearl Health's company update, STAT's investigation into Commure, and more
Aug 16, 2026
Hinge expands into the GI market, BofA's GLP-1 spending, Doximity sees strong demand for AI search tool, the fight over HCMC, and more
Aug 9, 2026
Q2 earnings takeaways (TDOC, HUM, CNC, ALHC, WAY, CI); musings on the future of providers & AI; and more
Aug 2, 2026
Q2 earnings: Molina, HCA, CHS, and Tenet report, highlighting ACA issues, commercial affordability challenges, and a winning strategy in high-acuity ASC cases
Jul 26, 2026
Q2 earnings season kicks off, OpenEvidence turns down a $20b valuation, Cadence's company presentation, musing on the PFS, and more
Jul 19, 2026
Kaiser's AI call center issues; Evidenced's new $24m fund; an OB/GYN for billionaires; and a wild week of lawsuits
Jul 12, 2026
Cityblock acquires Homeward; musing about the state of agentic voice AI market after Prosper and Assort's funding rounds;
Jun 28, 2026
Experiencing an AI scribe in the wild, Thoreau's platform investment in Ensemble, a key blow to anti-tiering/steering clauses, and the emerging two-tier system
Jun 21, 2026
Musing on Hawai'i's VBC conundrum, 2032 as a healthcare election, Hinge's investor day, Abridge's bid to be a clinical intelligence layer, and more
Jun 14, 2026
A musing on fraud, the ever growing autism market, legal debates over out-of-network pricing, and more
Jun 7, 2026
Musing on $100 billion healthcare AI companies, the impact of GLP-1s, conversations about primary care access, and more
May 31, 2026
Musing on PhRMA's access argument and the TAM for drugs; HCAT, HIMS, and DOCS drop on earnings; digital health pushes back on ACCESS and more
May 17, 2026